In February 2022, the Indian pharmaceutical company Cadila Healthcare's respiratory segment's Deriphyllin and Cardiac segment's Atorva had the highest market share at 2.8 percent. Cadila Healthcare is part of the Zydus group and is one of the leading pharmaceutical companies in India.
Distribution of therapy drugs manufactured by Cadila Healthcare in India in February 2022
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Sawai Pharmaceutical's number of employees FY 2013-2022
- Premium Statistic Sawai Pharmaceutical's number of patents FY 2013-2022
- Premium Statistic Sun Pharma's market share of therapy drugs India 2022
- Premium Statistic Revenue Cadila Healthcare India 2022, by leading therapy drug
- Premium Statistic Growth rate of therapy drugs by Cadila Healthcare India 2022
- Premium Statistic Alembic Pharma India revenue 2022, by leading therapy drug
- Premium Statistic Sun Pharma's revenue India 2022, by leading therapy drug
- Premium Statistic Sawai Pharmaceutical's total assets FY 2011-2020
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
About the region
10
- Premium Statistic MAT of therapies in Indian pharma 2022
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Growth rate of top therapies in Indian pharmaceuticals 2022
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic HAL sales turnover FY 2014-2023
- Premium Statistic HAL net profit FY 2014-2023
- Premium Statistic KAPL production value FY 2014-2022
- Premium Statistic KAPL sales value FY 2014-2022
- Premium Statistic BCPL's production value FY 2014-2023
- Premium Statistic BCPL net profit FY 2014-2023
Selected statistics
4
Other regions
10
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
- Premium Statistic Total savings of top generic drugs in U.S. 2022
- Basic Statistic Medicine spending in emerging pharmaceutical markets 2026
- Premium Statistic Peru's pharmaceutical and hygiene import value 2014-2018
- Premium Statistic Largest domestic pharma companies in Brazil 2015
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2022
- Premium Statistic End market sales volume of pharmaceutical industry in China 2012-2022
- Basic Statistic Value share of generic pharmaceuticals market in Czechia 2011-2021
- Basic Statistic Value of pharmaceutical sales in Estonia 2002-2022
- Basic Statistic Value of pharmaceutical sales in Finland 2003-2021
Related statistics
10
- Premium Statistic RDPL total turnover FY 2017-2019
- Premium Statistic BCPL turnover 2014-Q3 2018
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic R&D spending by top Indian pharmaceutical companies India FY 2020
- Premium Statistic Indian pharmaceutical export value FY 2012-2024
- Premium Statistic Indian pharmaceutical export share FY 2020, by region
- Premium Statistic Hindustan Antibiotics production value of FY 2014-2023
- Premium Statistic Proposed investment value in drugs and pharmaceuticals sector in India FY 2011-2022
- Basic Statistic Market share of cardiac sales India FY 2020, by leading company
- Basic Statistic Penetrated market share in cardiac segment India FY 2020, by leading company
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- M&A capacities - changes for the global pharma industry 2008-2015
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- M&A capacities - changes for the global pharma industry 2008-2015
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
Motilal Oswal Group. (March 8, 2022). Distribution of therapy drugs manufactured by Cadila Healthcare in India in February 2022 [Graph]. In Statista. Retrieved April 28, 2024, from https://www.statista.com/statistics/1096981/india-cadila-healthcare-therapy-drugs-market-share/
Motilal Oswal Group. "Distribution of therapy drugs manufactured by Cadila Healthcare in India in February 2022." Chart. March 8, 2022. Statista. Accessed April 28, 2024. https://www.statista.com/statistics/1096981/india-cadila-healthcare-therapy-drugs-market-share/
Motilal Oswal Group. (2022). Distribution of therapy drugs manufactured by Cadila Healthcare in India in February 2022. Statista. Statista Inc.. Accessed: April 28, 2024. https://www.statista.com/statistics/1096981/india-cadila-healthcare-therapy-drugs-market-share/
Motilal Oswal Group. "Distribution of Therapy Drugs Manufactured by Cadila Healthcare in India in February 2022." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1096981/india-cadila-healthcare-therapy-drugs-market-share/
Motilal Oswal Group, Distribution of therapy drugs manufactured by Cadila Healthcare in India in February 2022 Statista, https://www.statista.com/statistics/1096981/india-cadila-healthcare-therapy-drugs-market-share/ (last visited April 28, 2024)
Distribution of therapy drugs manufactured by Cadila Healthcare in India in February 2022 [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1096981/india-cadila-healthcare-therapy-drugs-market-share/